PURPOSE: To describe full explant pathology and radiographic correlation in @entity1 with @entity157 ( @entity157 ) treated with irreversible electroporation (IRE) who subsequently underwent liver transplant. MATERIALS AND METHODS: In a retrospective study, 6 @entity1 who had undergone IRE for @entity157 and subsequent orthotopic liver transplant during the period 2011-2013 were evaluated. Of the 6 @entity1 , 4 had @entity1 -Pugh class A @entity82 , and 2 had class B @entity82 . Irreversible electroporation was performed for a single focal @entity157 with median @entity5 diameter of 22 mm (range, 6-26 mm). After IRE, follow-up multiphasic cross-sectional imaging was performed at 1 month and every 3 months thereafter until liver transplant. Mean time between IRE and transplant was 10 months (range, 3-17 mo). Assessment of imaging response was based on modified Response Evaluation Criteria In @entity5 . Liver explants were evaluated for @entity39 and viable @entity189 in @entity5 . RESULTS: After IRE, all @entity5 showed a complete response on follow-up imaging. Five @entity5 showed complete pathologic @entity39 without any viable @entity189 , sharply demarcated from the surrounding @entity99 . Bile ducts within the treatment area were preserved. @entity5 treated with a bipolar IRE probe had < 5% viable @entity189 cells at the periphery. CONCLUSIONS: This study demonstrates the efficacy of IRE for @entity157 based on pathologic evaluation and correlation to radiologic findings.

Irreversible Electroporation Can Effectively Ablate XXXX to @entity39 .

@entity1 :: ('9606', 'Species') :: ['Child', 'patients'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'IRE-treated tumors', 'A single tumor', 'Solid Tumors', 'tumors'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic parenchyma']
@entity157 :: (MESH:D006528,Disease) :: ['Hepatocellular Carcinoma']
